Trial Profile
Depression spectrum disorder and differential effects of newer antidepressants on road safety. [Depressions-Spektrums-Störung und differenzielle Effekte neuerer Antidepressiva auf die Verkehrssicherheit].
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2012
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary) ; Bupropion (Primary) ; Escitalopram (Primary) ; Mirtazapine (Primary) ; Reboxetine (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- 05 Jun 2012 New trial record